LSG2G

Beginner's Mind with Christian Soschner is your lens into business and investing in deep tech.

06/11/2024

🌟 Reflecting on a memorable experience at BIO-Europe’s 30th anniversary in Stockholm! 🌟

Being part of the “Thank You for the Music” panel was such a privilege—an insightful, engaging conversation on life sciences, innovation, and the trends shaping our industry.

Special thanks to Millie Nelson for her excellent moderation, creating a space for each voice to shine and guiding the audience through the key takeaways.

And what a fantastic lineup alongside me: Cormac Sheridan Mike Ward and Jonathan Smith—each bringing unique insights and expertise that added incredible value to our discussion.

The full panel is available to rewatch in the partnering system for those who missed it.

A dynamic session filled with energy, perspectives, and future-focused ideas!

Big thanks to Michelle Cheesbrough and the entire EBD Group team for organizing such a memorable event. Your dedication and vision made this anniversary celebration a standout.

Now, I’m counting down to BIO-Europe 2025 in Vienna and already looking forward to reconnecting with everyone at BIO in Milan next spring.

21/10/2024

You're the CEO of a promising startup, fresh off a Series B.

Things are looking good—but what happens next?

As you push for a Series C or even a D, the road narrows.

Fewer investors, fewer acquirers.

And raising the next round?

It’s not enough just to grow—you need to convince institutional investors you’re worth billions.

But how?

Here’s the harsh truth:

To let your VCs shine, you need to provide them with a 10x to 100x exit. That means, with a $500M valuation, your company needs to hit somewhere between $5 billion and $500 billion in value.

Think about it—how many companies can buy you out at that level? Not many.

But the public market can.

That’s where the big institutional players—people with a mindset like Charlie Munger—wait for opportunities.

And they are not looking for flashy startups; they want solid, long-term investment cases.

So, how do you make your company attractive to these investors?

It starts with understanding their mindset—just like Charlie Munger’s principles that guide the best in business and investing.

Step 1: 𝐌𝐚𝐬𝐭𝐞𝐫 𝐭𝐡𝐞 𝐀𝐫𝐭 𝐨𝐟 𝐈𝐧𝐯𝐞𝐫𝐬𝐢𝐨𝐧 𝐓𝐡𝐢𝐧𝐤𝐢𝐧𝐠
Munger teaches us to think backward—identify what could go wrong and work backward to avoid those pitfalls. As a CEO, this means understanding what makes institutional investors walk away and structuring your company to avoid these red flags.

Step 2: 𝐂𝐨𝐦𝐩𝐨𝐮𝐧𝐝 𝐭𝐡𝐞 𝐑𝐢𝐠𝐡𝐭 𝐌𝐨𝐯𝐞𝐬
Just like compound interest builds wealth, small, consistent improvements in your company’s governance, culture, and financial health make you more attractive over time. The institutional investors you’re targeting are not impressed by fast growth—they’re looking for consistent, sustainable improvement.

Step 3: 𝐆𝐞𝐭 𝐭𝐡𝐞 𝐈𝐧𝐜𝐞𝐧𝐭𝐢𝐯𝐞𝐬 𝐑𝐢𝐠𝐡𝐭
What motivates your team today won’t cut it tomorrow. If you want to scale to a $5B+ valuation, you need to align your company's goals with those of public market investors—understanding the incentives that drive them.

When you apply these principles—avoiding cognitive biases, fostering the right culture, and aligning with investor expectations—you’re not just building a company; you’re building a long-term, investment-worthy powerhouse.

The kind of business that goes beyond a Series C and becomes a public market darling.

The reward?

You stop worrying about the next round and start preparing for an IPO—or, better yet, an acquisition exit that makes your VCs rave about you for decades. But it all starts with adopting the right mindset.

If you want to learn more about how to apply these timeless principles to your business, tune in to my latest podcast episode.

In this episode, I break down the 9 core principles from Poor Charlie’s Almanack that every CEO needs to know, especially when navigating the tricky waters of Series C and beyond.

Your success might depend on it!

🔗 Ready to dive deep into Charlie Munger’s wisdom and transform how you think about business and investing?

Here are the links you need:

🎧 Listen to the full podcast episode here: [https://www.buzzsprout.com/779930/episodes/15964204]

📺 Watch it on YouTube: [https://youtu.be/grVZJiHqSqg]

📚 Grab the book "Poor Charlie’s Almanack" on Amazon: [https://amzn.to/4hcJHMa]

Don’t miss out!

26/05/2024

Dr. Luis Pareras, neurosurgeon turned VC, reveals his unique framework for decoding the future of biotech and building groundbreaking companies.

� Future Rules: Luis' strategies for predicting and shaping healthcare trends.
� From Idea to Patient: How groundbreaking ideas transition into medical advancements.
� Investing in Tomorrow: The crucial role of ex*****on in transforming healthcare.

Dr. Pareras' bold vision and Invivo Ventures' track record bring a fresh perspective to venture capital.

Engage with us, share your thoughts, and let others know!

Your participation helps us bring more insights to the VC and startup community.

29/01/2024

🚀 𝐍𝐚𝐯𝐢𝐠𝐚𝐭𝐢𝐧𝐠 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐓𝐞𝐜𝐡 𝐄𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧: 𝐈𝐧𝐬𝐢𝐠𝐡𝐭𝐬 𝐟𝐫𝐨𝐦 𝐃𝐚𝐯𝐢𝐝 𝐃𝐚𝐧𝐚

I'm excited to present a new episode featuring a captivating conversation with David DANA, the mastermind at the European Investment Fund (EIF).

In this episode, David shares his insights on driving Europe's technological sovereignty. He delves into the transformative power of AI, Blockchain, and Quantum Technologies, and how these are shaping Europe's future in the global tech market.

Join us as we uncover how David's strategic vision and leadership at EIF are catalyzing Europe's journey towards becoming a technological powerhouse.

𝐇𝐞𝐫𝐞 𝐚𝐫𝐞 7 𝐨𝐟 𝐦𝐲 𝐛𝐢𝐠𝐠𝐞𝐬𝐭 𝐭𝐚𝐤𝐞𝐚𝐰𝐚𝐲𝐬: 👇

🌍 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐑𝐨𝐥𝐞 𝐢𝐧 𝐆𝐥𝐨𝐛𝐚𝐥 𝐓𝐞𝐜𝐡: [00:06:42]
"Europe has a role to play in the global market."

💡 𝐄𝐦𝐛𝐫𝐚𝐜𝐢𝐧𝐠 𝐑𝐢𝐬𝐤 𝐟𝐨𝐫 𝐑𝐞𝐰𝐚𝐫𝐝: [00:27:34]
"If you don't take the risk, you will not get the rewards."

🔬 𝐐𝐮𝐚𝐧𝐭𝐮𝐦 𝐓𝐞𝐜𝐡 𝐑𝐞𝐯𝐨𝐥𝐮𝐭𝐢𝐨𝐧: [00:34:50]
"Quantum technologies are at the beginning of something potentially huge."

🌐 𝐎𝐩𝐞𝐧𝐧𝐞𝐬𝐬 𝐢𝐧 𝐓𝐞𝐜𝐡 𝐓𝐫𝐚𝐧𝐬𝐟𝐞𝐫: [00:46:25]
"Opening to other shareholders helps to value and support the ecosystem more effectively."

💼 𝐒𝐭𝐫𝐚𝐭𝐞𝐠𝐢𝐜 𝐂𝐚𝐩𝐢𝐭𝐚𝐥 𝐃𝐞𝐩𝐥𝐨𝐲𝐦𝐞𝐧𝐭: [01:04:16]
"We need to generate returns; it's not just about investing, it's about deploying."

🧠 𝐄𝐮𝐫𝐨𝐩𝐞'𝐬 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐯𝐞 𝐂𝐚𝐩𝐚𝐜𝐢𝐭𝐲: [01:20:30]
“Europe has the capacity, knowledge, and brains to innovate and change the world.”

🙌 𝐄𝐦𝐩𝐨𝐰𝐞𝐫𝐢𝐧𝐠 𝐋𝐞𝐚𝐝𝐞𝐫𝐬𝐡𝐢𝐩: [01:27:51]
"We need to empower others by trusting them, giving them autonomy and responsibility."

Tune in for an in-depth exploration of these topics and more. (Links to the full episode in the comments)

Which insights from David Dana resonated with you the most?

Like, comment, and share with those who would benefit from this content. Your support helps us grow the show and attract more incredible speakers like David, delivering insightful content for free. 🌟🇪🇺

24/12/2023

🎄 Merry Christmas to The Facebook Community 🌟

In the spirit of the festive season, I'm excited to share my latest newsletter with you. It's a blend of reflection, gratitude, and insights from the world of deep tech, rooted in the philosophies that have shaped my journey.

🔗 Read the full letter here: [https://open.substack.com/pub/lsg2g/p/harmonizing-spirits-navigating-the?r=bxlfd&utm_campaign=post&utm_medium=web]

Join me as we explore the values of understanding, cooperation, and kindness, crucial for both life and the dynamic world of startups and investing.

Wishing everyone a season filled with peace, joy, and inspiration.

🌟 A Merry Christmas y’all - Christian Soschner

Adresse

Vienna

Telefon

436763551782

Webseite

https://linktr.ee/LSG2G

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von LSG2G erfährt. Ihre E-Mail-Adresse wird nicht für andere Zwecke verwendet und Sie können sich jederzeit abmelden.

Service Kontaktieren

Nachricht an LSG2G senden:

Videos

Fast Forward Thinking: The Playbook for Biotech Innovation & Investment

Dr. Luis Pareras, neurosurgeon turned VC, reveals his unique framework for decoding the future of biotech and building groundbreaking companies. � Future Rules: Luis' strategies for predicting and shaping healthcare trends. � From Idea to Patient: How groundbreaking ideas transition into medical advancements. � Investing in Tomorrow: The crucial role of execution in transforming healthcare. Dr. Pareras' bold vision and Invivo Ventures' track record bring a fresh perspective to venture capital. Engage with us, share your thoughts, and let others know! Your participation helps us bring more insights to the VC and startup community.